Week Ending May 17, 2021

Tracing Steps of Clinical Research in Lung Cancer
“Compared with decades ago, survival times for patients with lung cancer have dramatically increased, thanks to the introduction of targeted therapies and immune checkpoint inhibitors. Since these initial advances, investigators have focused on ways to further these results, by overcoming mechanisms of innate and acquired resistance across modalities and by discovering additional biomarkers of response.”

Durvalumab, Tremelimumab With Chemotherapy Shows Overall Survival Benefit in Non-Small Cell Lung Cancer
“Positive high-level results from the final analysis of the phase 3 POSEIDON trial showed the combination of durvalumab (Imfinzi, AstraZeneca), tremelimumab, and chemotherapy demonstrated a statistically significant and clinically meaningful overall survival (OS) benefit versus chemotherapy alone, according to a press release.”

Hybrid International Lung Cancer Congress Focuses on Multimodality Treatment
“Roy S. Herbst, MD, PhD, discussed the upcoming conference on July 29-31, which will follow a hybrid format with some faculty and attendees participating online and others participating in person.”

Why we need to improve rates of early diagnosis in never-smoking lung cancer—a patient-led initiative
“Razia was thirty-five years old when she was diagnosed with stage IV lung cancer. She is the mother of three young daughters and was healthy and active. She had never smoked. She was eventually diagnosed nearly a year after she first presented with symptoms.”

Lucence Launches US Validation Study for Liquid Biopsy in Lung Cancer
“NEW YORK – Precision oncology company Lucence said Tuesday that it has begun the first US validation study of its sequencing-based LiquidHallmark liquid biopsy assay versus tissue biopsy in detecting guideline-recommended biomarkers in lung cancer.”

VIDEO:
Faith and science sustaining recovering Newton lung cancer patient
“NEWTON, Texas (KTRE) – A persistent cough, thought to be allergies by some doctors, turned out to be the first sign of lung cancer for a Newton woman. The non-smoker was as persistent as the symptom when it came to listening to her body.”

Lung Association Turquoise Takeover Spreads Hope For Those Facing Lung Cancer During Pandemic
“CHICAGO, May 11, 2021 /PRNewswire/ — The COVID-19 pandemic has been a stark reminder of the importance of lung health, especially for those with lung diseases. For many with lung cancer, the burden has become more acute, with the pandemic adding more challenges, such as increased risk of complications from COVID-19 and changes or delays in treatment.”